Key result
The PHQ-9 and GAD-7 demonstrated favorable screening properties for detecting anxious-misery disorders in cardiovascular disease patients, with the PHQ-9 yielding an AUC of 0.873.
Why the study?
It remains poorly understood whether routine screening in cardiovascular disease populations identifies the broader clusters of disorders that co-occur within individuals, specifically anxious-misery and fear.
Do self-report questionnaires (PHQ-9, GAD-7) accurately identify internalizing disorder clusters (anxious-misery and fear) in recently hospitalized cardiovascular disease patients compared to a structured clinical interview?
Cross-Sectional (n=85)
Single-blind
No
Do self-report questionnaires (PHQ-9, GAD-7) accurately identify internalizing disorder clusters (anxious-misery and fear) in recently hospitalized cardiovascular disease patients compared to a structured clinical interview?
The PHQ-9 and GAD-7 are reliable screening tools for detecting anxious-misery disorders in recently hospitalized cardiovascular disease patients, supporting routine screening guidelines.
Supports screening in hospitalized CVD patients; leaves open prospective validation before routine adoption.
Depression and anxiety disorders are common among cardiovascular disease (CVD) populations, leading several cardiology societies to recommend routine screening to streamline psychological interventions. However, it remains poorly understood whether routine screening in CVD populations identifies the broader groups of disorders that cluster together within individuals, known as anxious-misery and fear. This study examines the screening utility of four anxiety and depression questionnaires to identify the two internalizing disorder clusters; anxious-misery and fear. Patients with a recent hospital admission for CVD (n = 85, 69.4% males) underwent a structured clinical interview with the MINI International Neuropsychiatric Interview. The participants also completed the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder (GAD-7) scale, Overall Anxiety Severity Impairment Scale (OASIS), and the stress subscale of the Depression Anxiety Stress Scale (DASS). The PHQ-9 and the GAD-7 yielded appropriate screening properties to detect three different iterations of the anxious-misery cluster (sensitivity > 80.95% and specificity > 82.81%). The GAD-7 was the only instrument to display favorable screening properties to detect a fear cluster omitting post-traumatic stress disorder (PTSD) but including obsessive-compulsive disorder (OCD; sensitivity 81.25%, specificity 76.81%). These findings indicate that the PHQ-9 and GAD-7 could be implemented to reliably screen for anxious-misery disorders among CVD in-patients, however the receiver operating characteristics to detect fear disorders were contingent on the placement of PTSD and OCD within clusters. The findings are discussed in relation to routine screening guidelines in CVD populations and contemporary understandings of the internalizing disorders.
No takes yet. Share an insight, caveat, or question.
Grech et al. (2019) conducted a cross-sectional in Cardiovascular disease (n=85). Depression and anxiety screening questionnaires (PHQ-9, GAD-7, OASIS, DASS-stress) vs. MINI International Neuropsychiatric Interview was evaluated on Detection of anxious-misery cluster a using PHQ-9 (cut-off 6) (AUC 0.873, 95% CI 0.783-0.935). The PHQ-9 and GAD-7 demonstrated favorable screening properties for detecting anxious-misery disorders in cardiovascular disease patients, with the PHQ-9 yielding an AUC of 0.873.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: